Nanoparticles represent highly promising platforms for the development of imaging and
therapeutic agents, including those that can either be detected via more than one imaging …

Cell membrane coated nanoparticles (NPs) is a biomimetic strategy developed to engineer
therapeutic devices consisting of a NP core coated with membrane derived from natural …

An overview of recent advances in the surface modification of colloidal particles to oppose
uptake by the mononuclear phagocyte system (MPS) is presented. First, we describe the …

The propensity of the hepatic macrophages (Kupffer cells) to rapidly intercept particulate
materials from the blood has been frustrating in redirecting intravenously injected …

Cell membranes have been continuously imitated and used for the modification of
nanoparticles (NPs) to improve NP biological properties. Cell membrane-coated NPs, where …

The cell membrane-coated nanoparticle is a biomimetic platform consisting of a
nanoparticulate core coated with membrane derived from a cell, such as a red blood cell …

Cell‐membrane‐coated nanoparticles have recently been studied extensively for their
biological compatibility, retention of cellular properties, and adaptability to a variety of …

Polymeric nanoparticles have been extensively studied for use as intravascular drug
delivery vehicles; however, their applications are limited by rapid clearance from circulation …

The development of cell membrane-modified biomimetic nanoparticles has extensively
increased during the past years due to their exceptional biocompatibility, evasion from the …

Nanoparticle‐based therapeutic, prevention, and detection modalities have the potential to
greatly impact how diseases are diagnosed and managed in the clinic. With the wide range …